8x8 Inc vs Revvity Inc — how do they compare? 8x8 Inc trades at $2.02 (market cap $279.31M), while Revvity Inc trades at $111.2 (market cap $12.42B). The key difference: Revvity Inc is far larger — about 44.5× 8x8 Inc's market cap, and Revvity Inc pays a 0.25% dividend while 8x8 Inc pays none. Which is the better fit depends on your goals.
| EGHT | RVTY | |
|---|---|---|
Market Cap | $279.31M | $12.42B |
Sector | Technology | Technology |
52-Week High | $2.76 | $117.75 |
52-Week Low | $1.59 | $82.26 |
Enterprise Value | $556.99M | $14.91B |
Dividend Yield | — | 0.25% |
Signals from Pluang's Aura AI — not financial advice
EGHT (8x8, Inc.) trades at $2.035, down 6.22% on the day. The stock shows a bullish technical signal from moving averages, though oscillators are neutral. Fundamentally, the company reported a net loss of $27.21M for 2025 but has beaten EPS estimates for three consecutive quarters. Recent news highlights product innovation with AI Routing and Pulse solutions, and the company was named a 2026 MetriStar Top Provider for CPaaS. Revenue grew to $715.07M in 2025, with a forecasted return to profitability in 2026.
The outlook hinges on the company's transition to profitability, projected for 2026 with a net profit of $2M. Investment opportunities include continued revenue growth, successful execution of new AI-driven products, and cost discipline. Key risks are the high P/E ratio of 197, significant long-term debt of $338.37M, and the challenge of sustaining recent earnings beats. Analyst sentiment is mixed but leans positive, with 39% Buy ratings.
No Aura AI signal available yet.
Trailing returns across standard periods
8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.
Read more on EGHT →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →